Effect of Actonel on Periodontal Health of Postmenopausal Women
Recruitment status was Recruiting
Hypothesis: Women who use Actonel (risedronate) for osteopenia will show beneficial periodontal effects.
University Hospital Case Medical Center has indicated that access to an investigational treatment associated with this study is available outside the clinical trial.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Prevention
|Official Title:||Effect of Actonel on Periodontal Health of Postmenopausal Women|
- Periodontal alveolar bone changes [ Time Frame: one year ] [ Designated as safety issue: Yes ]
- Periodontal attachment levels [ Time Frame: one year ] [ Designated as safety issue: Yes ]
|Study Start Date:||January 2008|
|Estimated Study Completion Date:||January 2011|
|Estimated Primary Completion Date:||January 2010 (Final data collection date for primary outcome measure)|
Women who use Actonel for osteopenia will show beneficial attachment loss, alveolar bone height and morphology as compared to those who do not when oral hygiene is corrected for.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00594334
|Contact: leena palomo, dds firstname.lastname@example.org|
|Contact: james liu, email@example.com|
|United States, Ohio|
|Cleveland, Ohio, United States, 44124|
|Principal Investigator: james liu, md|
|Principal Investigator:||james liu, md||UHCMC|
|Principal Investigator:||leena palomo, dds msd||uhcmc|